Genic Co., Ltd. (KOSDAQ:123330)

South Korea flag South Korea · Delayed Price · Currency is KRW
28,300
-600 (-2.08%)
At close: Apr 28, 2026
22.25%
Market Cap 221.44B
Revenue (ttm) 78.20B
Net Income (ttm) 18.89B
Shares Out 7.82M
EPS (ttm) 2,414.00
PE Ratio 11.72
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 166,667
Average Volume 213,392
Open 29,000
Previous Close 28,900
Day's Range 27,800 - 29,000
52-Week Range 15,570 - 44,100
Beta 0.89
RSI 48.76
Earnings Date Apr 2, 2026

About Genic

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and ... [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2001
Employees 324
Stock Exchange KOSDAQ
Ticker Symbol 123330
Full Company Profile

Financial Performance

In 2025, Genic's revenue was 78.20 billion, an increase of 56.68% compared to the previous year's 49.91 billion. Earnings were 18.89 billion, an increase of 149.73%.

Financial Statements

News

There is no news available yet.